ContraFect

YTD

ALL

Why Robinhood?

You can watch ContraFect and buy or sell other stocks, ETFs, and their options commission-free!

About CFRX

ContraFect Corp. is a clinical stage biotechnology company , which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza.

CEO

Roger J. Pomerantz

CEORoger J. Pomerantz

Employees

Employees20

Headquarters

Yonkers, New York

HeadquartersYonkers, New York

Founded

2008

Founded2008

Employees

Employees20

CFRX Key Statistics

Market cap

343.44M

Market cap343.44M

Price-Earnings ratio

18.95

Price-Earnings ratio18.95

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.34

52 Week high$1.34

52 Week low

$0.2693

52 Week low$0.2693